Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
Park IN, et al. Among authors: kim ds, kim mn, kim ws, kim wd.
J Antimicrob Chemother. 2006 Sep;58(3):701-4. doi: 10.1093/jac/dkl298. Epub 2006 Jul 19.
J Antimicrob Chemother. 2006.
PMID: 16857689
Clinical Trial.